Monthly Archives: January 2013

Journal of Otolaryngology-Head & Neck Surgery joins BioMed Central


Journal of Otolaryngology-Head & Neck Surgery, the official publication of the Canadian Society of Otolaryngology-Head and Neck Surgery, has today published its first articles following transfer to BioMed Central. The journal publishes original research, reviews, commentaries and short reports on all aspects and sub-specialties of otolaryngology-head & neck surgery, including, for example, pediatric and geriatric… Read more »


World Allergy Organization Journal is now open access

World_Allergy_Organization_Journal _70x70

World Allergy Organization Journal (WAO Journal) has published its first open access articles with BioMed Central today. As the official Journal of the World Allergy Organization, the journal will publish WAO position papers, statements and guidelines, along with original research, clinical reviews and epidemiological studies that contribute to current knowledge in patient care. The articles… Read more »


Adult-onset immunodeficiency: the rheumatologist's role

Immunodeficiency is a state in which the immune system’s ability to fight infectious disease is compromised or entirely absent. As Prof. Hans-Hartmut Peter (University Hospital Freiburg) describes in his editorial, published in Arthritis Research & Therapy, there are increasing numbers of patients with symptoms of a dysfunctional immune system being seen in rheumatology clinics. Symptoms… Read more »


'Peripheral Biomarkers' – special series call for submissions

Alzheimer’s Research & Therapy is now accepting research submissions for consideration in a special series on peripheral biomarkers, planned for publication in summer 2013. The publication of these articles will be co-ordinated with a series of commissioned reviews and opinions, edited by Douglas Galasko (UCSD) and written by leaders in the field including Thomas Kodadek… Read more »


Road safety: Time for a Decade of Action

Overturned truck in Ghana_copyright WHO

With an estimated 3,500 road traffic related deaths every day, road casualties and fatalities are an urgent global concern. For those between 5 and 44 years, road traffic injuries are among the top three leading causes of death, and more alarmingly, for 15-29 year olds, road traffic accidents are the leading cause of death. In… Read more »


Progression in the field of Emergency Medicine: highlights from the 5th National Emergency Medicine conference in London

Patients requiring immediate and urgent medical care for acute illnesses or injuries will fall under the care of those in the emergency medicine sector. These healthcare professionals include paramedics, who deal with pre-hospital care, and also includes emergency department physicians and nurses, and a growing body of clinical researchers in this area. Given that decisions… Read more »


Innovations in interventional cardiology: Technology, funding and political strategies

The number of interventional cardiology technologies is growing, and these devices will require clinical implementation, improved performance and standardized regulatory processes for worldwide patient benefit. These challenges are apparent in western medicine, and partnerships such as the Yale-UCL collaborative have been developed to facilitate EU-US innovations in cardiovascular medicine. Engineering considerations, trans-Atlantic regulatory procedures, healthcare… Read more »


A few too many? Alcohol as a risk factor for dementia

‘Alcohol-related cognitive impairment’ is expected to become more common in the future as levels of alcohol consumption increase worldwide. As symptoms can be very similar to Alzheimer’s disease, there is increasing clinical demand to distinguish this as a separate disorder. Alcohol-related cognitive disorders are currently split into two categories: alcohol related dementia (ARD) and alcohol-induced… Read more »


miRNA biomarkers in osteosarcoma: crossing a new bridge

GM logo 1

Osteosarcoma is the most common type of bone tumor, but the lack of good biomarkers to predict the outcome of standard treatment has so far prevented patient stratification and therapy evolution. Gene expression signatures, including microRNA (miRNA) profiles, have been suggested to have predictive value for the response of a tumor to chemotherapy, but the… Read more »